Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

AR splice variant 7

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

AR amplification (5)

AR amplification (5)

›

AR splice variant 7	Prostate Cancer	AR splice variant 7	Prostate Cancer	abiraterone acetate Resistant: A2 - Guideline abiraterone acetate Resistant : A2	abiraterone acetate Resistant: A2 - Guideline abiraterone acetate Resistant : A2
AR splice variant 7	Prostate Cancer	AR splice variant 7	Prostate Cancer	enzalutamide Resistant: A2 - Guideline enzalutamide Resistant : A2	enzalutamide Resistant: A2 - Guideline enzalutamide Resistant : A2
AR splice variant 7	Prostate Cancer	AR splice variant 7	Prostate Cancer	darolutamide + dordaviprone Resistant: D – Preclinical darolutamide + dordaviprone Resistant : D	darolutamide + dordaviprone Resistant: D – Preclinical darolutamide + dordaviprone Resistant : D
AR splice variant 7	Prostate Cancer	AR splice variant 7	Prostate Cancer	enzalutamide + HSK38008 Sensitive: D – Preclinical enzalutamide + HSK38008 Sensitive : D	enzalutamide + HSK38008 Sensitive: D – Preclinical enzalutamide + HSK38008 Sensitive : D
AR splice variant 7	Prostate Cancer	AR splice variant 7	Prostate Cancer	HSK38008 Sensitive: D – Preclinical HSK38008 Sensitive : D	HSK38008 Sensitive: D – Preclinical HSK38008 Sensitive : D